Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novanta Inc. - Common Shares (NQ:NOVT)

113.91 -0.62 (-0.54%)
Streaming Delayed Price Updated: 3:54 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novanta Inc. - Common Shares

< Previous 1 2 3 Next >
3 Profitable Stocks We Keep Off Our Radar
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
Electronic Components Stocks Q2 Earnings Review: Bel Fuse (NASDAQ:BELFA) Shines
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at electronic components stocks, starting... 
Via StockStory
3 Industrials Stocks That Fall Short
Whether you see them or not, industrials businesses play a crucial part in our daily activities. They are also bound to benefit from a friendlier regulatory environment with the Trump administration,... 
Via StockStory
Topics Government Stocks
Astronics, nLIGHT, Kadant, Montrose, and Novanta Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after an unexpectedly sharp rise in wholesale inflation fueled concerns about rising costs and their impact on corporate profits. The primary catalyst... 
Via StockStory
Topics Artificial Intelligence Economy World Trade
NOVT Q2 Deep Dive: Medical Device Growth Offset by Guidance Caution and Trade Uncertainty
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 2.2% year on year to $241 million. On the other hand, next... 
Via StockStory
Topics World Trade
Novanta (NOVT) Q2 Revenue Rises 2.2%
Via The Motley Fool
Topics Economy
Novanta’s (NASDAQ:NOVT) Q2: Beats On Revenue But Quarterly Revenue Guidance Misses Expectations
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) announced better-than-expected revenue in Q2 CY2025, with sales up 2.2% year on year to $241 million. On the other hand, next... 
Via StockStory
Earnings Scheduled For August 5, 2025
 
Via Benzinga
Earnings Scheduled For May 6, 2025
 
Via Benzinga
Earnings Scheduled For February 25, 2025
 
Via Benzinga
Novanta (NOVT) Q2 Earnings Report Preview: What To Look For
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) will be reporting earnings this Tuesday before market open. Here’s what to expect. 
Via StockStory
3 Cash-Producing Stocks Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
3 Profitable Stocks Walking a Fine Line
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
3 Industrials Stocks Facing Headwinds
Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence... 
Via StockStory
Topics Economy Stocks
Q1 Earnings Outperformers: Novanta (NASDAQ:NOVT) And The Rest Of The Electronic Components Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Novanta (NASDAQ:NOVT) and its peers. 
Via StockStory
NOVT Q1 Earnings Call: Resilient Performance Amid Trade Headwinds and Strategic Acquisition
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.1% year on year to $233.4 million. On the other hand, next... 
Via StockStory
Topics World Trade
Novanta’s (NASDAQ:NOVT) Q1 Earnings Results: Revenue In Line With Expectations But Stock Drops 12.3%
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.1% year on year to $233.4 million. On the other hand, next... 
Via StockStory
Novanta (NOVT) Q1 Earnings Report Preview: What To Look For
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) will be announcing earnings results tomorrow before the bell. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
3 Small-Cap Stocks with Questionable Fundamentals
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Topics Economy Supply Chain
Reflecting On Electronic Components Stocks’ Q4 Earnings: Novanta (NASDAQ:NOVT)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the electronic components stocks, including Novanta (NASDAQ:NOVT) and its peers. 
Via StockStory
Electronic Components Stocks Q4 Recap: Benchmarking Vishay Precision (NYSE:VPG)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at electronic components stocks, starting... 
Via StockStory
3 Reasons NOVT is Risky and 1 Stock to Buy Instead
Novanta’s stock price has taken a beating over the past six months, shedding 21.9% of its value and falling to a new 52-week low of $133.58 per share. This was partly due to its softer quarterly... 
Via StockStory
Reasonable Growth, Debt Levels, and a High ROIC Make NOVANTA INC (NASDAQ:NOVT) Appealing to Quality Investors.
A fundamental analysis of (NASDAQ:NOVT) shows NOVANTA INC (NASDAQ:NOVT) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
2 High-Flying Stocks to Own for Decades and 1 to Brush Off
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
Novanta (NASDAQ:NOVT) Misses Q4 Sales Targets
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 12.5% year on year to $238.1 million. Next quarter’s revenue... 
Via StockStory
Novanta (NOVT) Q4 Earnings: What To Expect
Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) will be announcing earnings results tomorrow morning. Here’s what to look for. 
Via StockStory
3 Reasons NOVT is Risky and 1 Stock to Buy Instead
Over the last six months, Novanta’s shares have sunk to $149.65, producing a disappointing 17.7% loss - a stark contrast to the S&P 500’s 12.6% gain. This was partly driven by its softer quarterly... 
Via StockStory
Topics Stocks
Electronic Components Stocks Q3 In Review: Bel Fuse (NASDAQ:BELFA) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bel Fuse (NASDAQ:BELFA) and the best and... 
Via StockStory
A Look Back at Electronic Components Stocks’ Q3 Earnings: Allient (NASDAQ:ALNT) Vs The Rest Of The Pack
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the electronic components industry, including Allient (NASDAQ:ALNT) and its peers. 
Via StockStory
Q3 Earnings Highlights: Littelfuse (NASDAQ:LFUS) Vs The Rest Of The Electronic Components Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the electronic components industry, including Littelfuse (NASDAQ:LFUS) and its peers. 
Via StockStory
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.